MusclePharm(R) Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, announced a fulfillment agreement with IVitals that is expected to improve cash flow, reduce backorders, improve turnaround time on all orders and allow management to focus its time and resources on the marketing and selling of MusclePharm’s growing portfolio of products. The Company expects to achieve over $4 million in sales for the full year of 2010, which is over 300% growth compared to the same period last year. The rapid growth and strong customer demand for the MusclePharm products has created back orders for 5 of the 12 months in 2010. The new fulfillment agreement is expect to greatly improve the back orders for the remainder of 2010 and reduce the insufficient levels of stock needed to complete all orders. MusclePharm’s President, Cory Gregory stated, “This fulfillment agreement will reduce the cost and delivery time for all product shipments to our many retail and online customers. In addition, by outsourcing our fulfillment function, management will be able to focus our time and resources on expanding sales opportunities and enhancing our brand.” Mr. Gregory continued, “With rapid growth of 300% come a few growing pains such as back orders. I am pleased that we expect to achieve this growth in 2010 despite having 40% of our orders on back-order. However, with this fulfillment agreement, we have greatly improved our operating platform and believe we have rectified our back order situation. With a dramatically improved operating platform and leading nutritional supplements that are 100% free of any banned substances we are very well positioned for continued strong growth in 2011.” About MusclePharmHeadquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company’s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com. Forward-looking StatementsMusclePharm Corporation believes the information set forth in this Press Release may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in “Risk Factors” in Item 2.02 of the Company’s Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission. Contact:ICR
Investor Contact:
John Mills, Senior Managing Director
310.954.1105
CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
No comments:
Post a Comment